Nicola Flaum
Manchester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Clinical implementation of polygenic risk scores-updates on ancestry-adjusted PRS and their use in practice.
Journal: European journal of human genetics : EJHG
Published: July 02, 2026
Survival Outcomes With or Without Risk-Reducing Mastectomy in BRCA1 and BRCA2 Pathogenic Variant Carriers.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 04, 2026
Risk-reducing surgery, risk-reducing medication, and surveillance in young BRCA carriers with breast cancer: considering all the options.
Journal: Translational cancer research
Published: January 08, 2026
Clinical implementation of polygenic risk scores.
Journal: European journal of human genetics : EJHG
Published: November 18, 2025
Polygenic risk scores to refine Breast cancer screening and prevention strategies.
Journal: Personalized medicine
Published: November 13, 2025
Risk of ovarian cancer in women with a pathogenic or likely pathogenic variant in NBN: a systematic review and meta-analysis.
Journal: American journal of obstetrics and gynecology
Published: October 21, 2025
Clinical implementation of polygenic risk scores.
Journal: European journal of human genetics : EJHG
Published: July 22, 2025
High-grade serous ovarian cancer after bilateral salpingo-oophorectomy.
Journal: Journal of the National Cancer Institute
Published: November 30, 2024
Extended panel testing in ovarian cancer reveals BRIP1 as the third most important predisposition gene.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: April 13, 2024
Cross-cultural adaptation of the PROFFIT Instrument to measure financial toxicity in people living with cancer within a UK population.
Journal: Journal of cancer policy
Published: June 07, 2023
Optimization of polygenic risk scores in BRCA1/2 pathogenic variant heterozygotes in epithelial ovarian cancer.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: December 21, 2022
Is Reflex Germline BRCA1/2 Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?
Journal: Cancers
Published: December 04, 2022
Last Updated: 09/26/2026